Nyrada Inc - NYR share price
About Nyrada Inc
Nyrada Inc. is a biotechnology company focused on the discovery and development of small-molecule therapies, specifically targeting Transient Receptor Potential Canonical (TRPC) ion channels. The Company’s lead candidate, NYR-BI03, has shown efficacy in both neuroprotection and cardioprotection. The NYR-BI03 has potential to fill a significant treatment gap targeting ischemia-reperfusion injury. NYR-BI03 additionally has the potential to provide dual protection for both the heart and brain from ischemia-reperfusion damage, helping prevent heart failure and neurological damage. Its Neuroprotection Program is a neuroprotectant drug to reduce the impact of long-term disability in patients who suffer a traumatic brain injury or ischaemic stroke. Its Cardioprotection Program is a cardioprotectant drug to reduce the damage to the heart following myocardial infarction (heart attack).
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Try Veye Free for 7 Days
Expert ASX stock picks, in-depth research & buy/sell signals — free for a full week.
No credit card required
Price Chart (NYR)
TOP ASX STOCKS Worth Watching
- ✓ Instant Access
- ✓ No Credit Card Required
- ✓ Free to join · No spam
Free to join · No spam · Unsubscribe anytime
By providing your details, you agree to Veye's Terms & Conditions, Privacy Policy, and Financial Services Guide and to receive marketing offers. Before you access our services, please read the Financial Services Guide available here.
Discover the Top ASX Stocks to Invest in 2026!
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Latest Article
